1. Home
  2. GKOS vs REYN Comparison

GKOS vs REYN Comparison

Compare GKOS & REYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • REYN
  • Stock Information
  • Founded
  • GKOS 1998
  • REYN 1947
  • Country
  • GKOS United States
  • REYN United States
  • Employees
  • GKOS N/A
  • REYN N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • REYN Office Equipment/Supplies/Services
  • Sector
  • GKOS Health Care
  • REYN Industrials
  • Exchange
  • GKOS Nasdaq
  • REYN Nasdaq
  • Market Cap
  • GKOS 5.8B
  • REYN 4.9B
  • IPO Year
  • GKOS 2015
  • REYN 2020
  • Fundamental
  • Price
  • GKOS $94.00
  • REYN $23.67
  • Analyst Decision
  • GKOS Strong Buy
  • REYN Hold
  • Analyst Count
  • GKOS 12
  • REYN 8
  • Target Price
  • GKOS $131.17
  • REYN $26.13
  • AVG Volume (30 Days)
  • GKOS 693.4K
  • REYN 845.7K
  • Earning Date
  • GKOS 11-03-2025
  • REYN 10-29-2025
  • Dividend Yield
  • GKOS N/A
  • REYN 3.89%
  • EPS Growth
  • GKOS N/A
  • REYN N/A
  • EPS
  • GKOS N/A
  • REYN 1.48
  • Revenue
  • GKOS $432,953,000.00
  • REYN $3,687,000,000.00
  • Revenue This Year
  • GKOS $28.79
  • REYN $0.87
  • Revenue Next Year
  • GKOS $25.65
  • REYN $1.88
  • P/E Ratio
  • GKOS N/A
  • REYN $15.99
  • Revenue Growth
  • GKOS 26.70
  • REYN N/A
  • 52 Week Low
  • GKOS $77.10
  • REYN $20.91
  • 52 Week High
  • GKOS $163.71
  • REYN $32.65
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 53.08
  • REYN 64.47
  • Support Level
  • GKOS $89.83
  • REYN $22.85
  • Resistance Level
  • GKOS $97.00
  • REYN $23.42
  • Average True Range (ATR)
  • GKOS 2.65
  • REYN 0.42
  • MACD
  • GKOS 0.39
  • REYN 0.03
  • Stochastic Oscillator
  • GKOS 71.27
  • REYN 68.56

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About REYN Reynolds Consumer Products Inc.

Reynolds Consumer Products Inc is a provider of household products. The firm is engaged in the production and sales of cooking products, waste and storage products, and tableware. It operates through four reportable segments namely, Reynolds Cooking and Baking, Hefty Waste and Storage, Hefty Tableware, and Presto Products. Reynolds Cooking and Baking segment produce branded and store brand aluminum foil, disposable aluminum pans, parchment paper, freezer paper, wax paper, butcher paper, plastic wrap, baking cups, oven bags and slow cooker liners.

Share on Social Networks: